Table 3: Comparisons of thyroid hormones in patients before and after WK* or sotalol treatments in the first investigation.

Before treatments
WK* treatment (91 cases)Sotalol treatment (89 cases) value ( value)**

FT3* (pmol/L)24.613 ± 5.05924.405 ± 5.006−0.278 (0.781)
FT4* (pmol/L)118.697 ± 29.213116.132 ± 28.266−0.598 (0.550)
TSH* (IU/mL)0.007 ± 0.0100.009 ± 0.1471.191 (0.235)

Three months after treatments
WK* treatment (91 cases)Sotalol treatment (89 cases) value ( value)**

FT3* (pmol/L)6.495 ± 3.7136.596 ± 3.7400.182 (0.855)
FT4* (pmol/L)21.447 ± 11.72721.655 ± 10.6120.125 (0.901)
TSH* (IU/mL)6.210 ± 10.0025.752 ± 8.915−0.324 (0.746)

WK: Wenxin Keli, FT3: free triiodothyronine, FT4: free thyroxine, and TSH: thyroid stimulating hormone; **analyzed by independent samples -test.